|
|
||||||||
Ann Thorac Surg 1996;62:950
© 1996 The Society of Thoracic Surgeons
lu, MD
uz Ta
demir, MD
Cardiovascular Surgery Clinic, Türkiye Yüksek
htisas Hastanesi, 06100 Sihhiye, Ankara Turkey
To the Editor:
We have read Simpson and associates' [1] article about nitroglycerin and spinal cord ischemia with great interest. They declared that nitroglycerin, like sodium nitroprusside, is harmful to the spinal cord because these agents act through the nitrous oxide system, which has been shown to play a role in excitatory amino-acidinduced neurologic injury and they lead to steal phenomenon.
Pharmacological dilation or shunt procedures do not always increase spinal cord blood flow, even if the distal pressure is increased significantly. Shunt procedures do not increase the blood flow to the thoracic spinal cord because of the high resistance of the anterior spinal artery above the arteria radicularis magna, which supplies the lower thoracic spinal cord. A shunt or pharmacologic vasodilation (nitroglycerin) does not always guarantee the adequacy of perfusion to the lower thoracic spinal cord. Therefore, to protect the lower thoracic spinal cord, the artery supplying this segment must be specifically dilated by pharmacologic means; otherwise, the lower thoracic spinal cord must be preserved with the use of hypothermia. Paraplegia cannot occur if the anterior spinal artery is large or dilated enough to satisfy the metabolic needs of this segment. In a previous study, papaverine was used to increase spinal cord blood flow because it reverses the basilar artery spasm observed during subarachnoid hemorrhage [2], and intrathecally administered papaverine reduces the risk of paraplegia [3]. We [4] and Grabitz and colleagues [5] also demonstrated that prostaglandins have the ability to decrease the risk of spinal cord injury. Prostaglandins have antiaggregant and cytoprotective effects during reperfusion [6]. Our belief is that that any vasodilator agent that increases the cyclic adenosine monophosphate level reduces the incidence of neurologic injury.
References
lu SF, Küçükaksu DS, Küplülü
, et al. Effects of prostacyclin on spinal cord ischemia: an experimental study. Surgery1993;114:369.[Medline]
lu SF, Küçükaksu DS, Bozdayi M, et al. Beneficial effects of prostacyclin treatment on reperfusion of the myocardium. Cardiovasc Surg1995;4:4058.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |